Fate Therapeutics
Price & Volume
Stats
See more52W Range | $1.91-$8.83 |
Market Cap | $314.3M |
Shares Short | 16M |
Financials
See moreRevenue (12 Mos) | $12.3M |
Revenue Growth (YoY) | 625.8% |
Gross Profit (12 Mos) | -$224.1M |
Diluted EPS | -$1.70 |
News
See moreYahoo Finance • 4 months ago
Billionaires Are Buying These 2 Beaten-Down Stocks. Are They Smart Buys for Your Portfolio?
Yahoo Finance • 6 months ago
Fate Therapeutics, Inc. (NASDAQ:FATE) Q1 2024 Earnings Call Transcript
Yahoo Finance • 8 months ago
Fate Therapeutics, Inc. (NASDAQ:FATE) Just Reported And Analysts Have Been Lifting Their Price Targets
Yahoo Finance • 8 months ago
Fate Therapeutics Inc (FATE) Reports Fourth Quarter and Full Year 2023 Financial Results
About
CEO | Mr. J. Scott Wolchko |
CFO | Mr. J. Scott Wolchko |
Address | 12278 Scripps Summit Drive, San Diego, CA, United States, 92131 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 181 |
